<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04981093</url>
  </required_header>
  <id_info>
    <org_study_id>2020-519</org_study_id>
    <nct_id>NCT04981093</nct_id>
  </id_info>
  <brief_title>Effect of Dexamethasone on Postoperative Inflammatory Factors</brief_title>
  <official_title>Effect of Dexamethasone on Postoperative Inflammatory Factors in Elderly Patients Undergoing Lunmbar Spine Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital of Ningxia Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General Hospital of Ningxia Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This topic foe randomized prospective study.Detection of elderly patients with lunmbar spinal&#xD;
      postoperative inflammatory substances in the blood and drainage of liquid level ,clear&#xD;
      whether low-dose dexamethasone can inhibit the inflammation, the observation of elderly&#xD;
      patients with lumbar spinal postoperative drainage star, to explor whether low-dose&#xD;
      dexamthasone can reduce postoperative incision drainage, thus impove the postoprative&#xD;
      drainage tube pull rate within three days, which in turn reduce because of the place a&#xD;
      retrograde infection caused by drainage tube.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 100 patients undergoing posterior lumbar disc fusion were randomly divided into&#xD;
      control group (group C,n=50) and dexamethasone group (group D,n=50). Group D was given&#xD;
      0.15mg/kg dexamethasone (2ml) intravenously after anesthesia induction. Group C was also&#xD;
      intravenously injected with 2ml normal saline after anesthesia induction.On this basis,&#xD;
      monitor the main results and secondary results&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 15, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the change of drainage fluid volume</measure>
    <time_frame>6 hours after surgery， the morning of 1, 2, and 3 days after surgery</time_frame>
    <description>Drainage fluid （ml）was collected and the volume of drainage fluid was recorded&#xD;
Until the drainage tube was pulled out,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the change of Inflammatory mediators in the drainage fluid</measure>
    <time_frame>6 hours after surgery， the morning of 1, 2, and 3 days after surgery</time_frame>
    <description>CRP(mg/ L) in postoperative drainage fluid was observed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the change of blood inflammatory mediators</measure>
    <time_frame>6 hours after surgery， the morning of 1, 2, and 3 days after surgery</time_frame>
    <description>Fasting blood was collected from each enrolled patient preoperatively, 6 hours after surgery and on the morning of 1, 2, and 3 days after surgery&#xD;
Fasting blood, blood samples were centrifuged (1500r/min, 15min) and serum was separated and placed in -80℃ deep low temperature refrigerator for measurement. The observation technique&#xD;
After the blood CRP(mg/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the change of blood routine white blood cell count</measure>
    <time_frame>6 hours after surgery， the morning of 1, 2, and 3 days after surgery</time_frame>
    <description>Fasting blood was collected from each enrolled patient preoperatively, 6 hours after surgery and on the morning of 1, 2, and 3 days after surgery&#xD;
Fasting blood, blood samples were centrifuged (1500r/min, 15min) and serum was separated and placed in -80℃ deep low temperature refrigerator for measurement. The observation technique&#xD;
After the blood blood routine white blood cell count</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Group Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group dexamethasone patients received intravenous injection after anesthesia induction&#xD;
Injection 0.15mg/kg dexamethasone (2ml）</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group Control patients were also given 2ml of normal saline intravenously after induction of anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone Injection</intervention_name>
    <description>Intravenous injection after induction of anesthesia&#xD;
Injection 0.15mg/kg dexamethasone (2ml)</description>
    <arm_group_label>Group Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>2ml of normal saline was injected intravenously after induction of anesthesia</description>
    <arm_group_label>Group Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients ≥65years of age&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) physical status 2-4&#xD;
&#xD;
          -  Elective or expedited non-cardiac surgery of at least 2 hours dura- tion under general&#xD;
             anaesthesia&#xD;
&#xD;
          -  Requiring a hospital stay of at least one postoperative night&#xD;
&#xD;
          -  A surgical skin incision &gt;5 cm in length or multiple incisions with a total incision&#xD;
             length of &gt;5 cm&#xD;
&#xD;
        Exclusion Criteria:·&#xD;
&#xD;
          -  Poorly controlled diabetes (HbA1c&gt;9.0%)&#xD;
&#xD;
          -  Endovascular procedure with a small (&lt;5 cm length) skin incision Ophthalmic surgery&#xD;
&#xD;
          -  Planned dexamethasone (or other corticosteroid) therapy (eg, history of intractable&#xD;
             PONV, maxillofacial surgery, intracranial neurosurgery)&#xD;
&#xD;
          -  Recent (&lt;2 weeks since end of treatment) infective episode requir- ing treatment with&#xD;
             antibiotics&#xD;
&#xD;
          -  Chronic antibiotic therapy (eg, for bronchiectasis, cystic fibrosis etc)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>General Hospital of Ningxia Medical University</name>
      <address>
        <city>Yinchuan</city>
        <state>Ningxia</state>
        <zip>750004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanxiang Ma</last_name>
      <phone>+86-13519591508</phone>
      <email>mahanxiang@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Corcoran TB, Myles PS, Forbes AB, O'Loughlin E, Leslie K, Story D, Short TG, Chan MT, Coutts P, Sidhu J, Cheng AC, Bach LA, Ho KM; Australian and New Zealand College of Anaesthetists Clinical Trials Network (ANZCA), and the Australian Society for Infectious Diseases (ASID) Clinical Research Network. The perioperative administration of dexamethasone and infection (PADDI) trial protocol: rationale and design of a pragmatic multicentre non-inferiority study. BMJ Open. 2019 Sep 6;9(9):e030402. doi: 10.1136/bmjopen-2019-030402.</citation>
    <PMID>31494615</PMID>
  </reference>
  <reference>
    <citation>Corcoran TB, Myles PS, Forbes AB, Cheng AC, Bach LA, O'Loughlin E, Leslie K, Chan MTV, Story D, Short TG, Martin C, Coutts P, Ho KM; PADDI Investigators; Australian and New Zealand College of Anaesthetists Clinical Trials Network; Australasian Society for Infectious Diseases Clinical Research Network. Dexamethasone and Surgical-Site Infection. N Engl J Med. 2021 May 6;384(18):1731-1741. doi: 10.1056/NEJMoa2028982.</citation>
    <PMID>33951362</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 14, 2021</study_first_submitted>
  <study_first_submitted_qc>July 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2021</study_first_posted>
  <last_update_submitted>July 27, 2021</last_update_submitted>
  <last_update_submitted_qc>July 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intravenous dexamethasone</keyword>
  <keyword>inflammation</keyword>
  <keyword>QoR15</keyword>
  <keyword>drainage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

